Finance News – Nektar Therapeutics
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Stock
Crypto Assets
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Bse
Sec
Eth
Ipo
Index
Solana
Trade
Earnings
Inflation
Revenue
Coinbase
Interest Rates
Token
China
Sensex
Wall Street
Nasdaq
Federal Reserve
Traders
Treasury
Gold
Nse
Bse Sensex
Economy
Usd
Profit
Tesla
Nifty
Sp 500
Trade War
Annual Inflation
Bajaj
Banking Stocks
Governance Structure
Earnings Potential
Videogame Business
Mclr
Service Exports
Bastion
Aatmanirbhar Bharat
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jun 24, 2025
Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results
The substantial increase in Nektar Therapeutics' share price reflects investor optimism following successful clinical trial outcomes for a new eczema treatment.
Read Full Article →